exhausted on glp 1 Fatigue from GLP-1 Injections GLP-1 Fatigue: Why It Happens

Indications: Type 2 Diabetes Mellitus (monotherapy or add-on therapy) Especially useful in patients who cannot tolerate metformin or sulfonylureas Can be used in elderly and patients with mild renal impairment Approved Agents in India: Sitagliptin (Januvia) Vildagliptin (Galvus) Saxagliptin (Onglyza) Linagliptin (Trajenta) No renal dose adjustment needed Alogliptin (Nesina) Dosing: Once daily oral dosing Some agents require renal dose adjustment (except Linagliptin) Often combined with metformin or SGLT2 inhibitors Side Effects: Nasopharyngitis, headache GI upset (mild) Rare: Acute pancreatitis, severe joint pain, skin reactions Saxagliptin may slightly increase risk of heart failure in some patients Advantages Over Other Classes: Weight neutral Low risk of hypoglycemia Well tolerated in the elderly Convenient once-daily dosing Limitations: Modest HbA1c reduction (0.50.8%) Not effective in Type 1 Diabetes Less potent than GLP-1 analogs or SGLT2 inhibitors Conclusion: DPP-4 inhibitors are a safe, effective, and well-tolerated option for many patients with T2DM especially those needing an add-on to metformin or who can't tolerate injectables

These are serious prescription medicines not quick-fix weight loss solutions

If you're feeling unusually tired, dizzy, or dealing with a persistent headache on your GLP-1 journey, the culprit is often simpler than you think

Ingredients, allergens, additives, nutrition facts, labels, origins, CO2 impact and information on product GLP-1 BOOSTER supergut

Discover what to order at popular chains with high-protein and balanced menu recommendations.

Buy GLP-1 (Japanese Edition): Read Kindle Store Reviews - Amazon.com